Xinyue Zhou

5PUBLICATIONS
36CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 06, 2025
Activation of a nongenetic AHR-ELMSAN1 axis optimizes BET-targeting therapy and suppresses leukemia stem cells in preclinical models.

Xinyue Zhou, Steven Moreira, Cecilia Restelli

|Feb 12, 2025
PTP Inhibition Improves the Macrophage Antitumor Immune Response and the Efficacy of Chemo- and Radiotherapy.

Nestor Prieto-Dominguez, Paran Goel, Oluwagbemiga A Ojo

|Oct 30, 2022
UTX loss alters therapeutic responses in KMT2A-rearranged acute myeloid leukemia.

Xinyue Zhou, Pengcheng Zhang, Sajesan Aryal

Pageof 1